Skip to main content
Home
Search
Multi-scale Atlas
NEW
Search for Drug ADMET Endpoint Profile (DAE)
NEW
Search for Drug Pharmacogenomic Perturbation Map (DPP)
NEW
Search for Drug-Molecule Activity Atlas (DMA)
NEW
Drug Development Portfolio
Search for Drug
Search for Combinatorial Drug (CBD)
Search for Repurposed Drug (RPD)
Drug-interacting Molecule
Search for Drug Therapeutic Target (DTT)
Search for Drug Transporter (DTP)
Search for Drug-Metabolizing Enzyme (DME)
Search for Drug Off-target (DOT)
Disease
Search for Disease
Download
Help
About
Details of the Drug Formulaction
General Information of Drug Formulation (ID: F18917)
Formulation Name
Repaglinide 2 mg tablet
Company
American Health Packaging
Pharmaceutical Drug(s) in Formulation
Drug Name
Drug ID
Indication
ICD 11
Status
Repaglinide
DM5SXUV
Diabetic complication
5A2Y
Approved
--------------------
Pharmaceutical Excipient(s) in Formulation
Excipient Name
Excipient ID
PubChem CID
Functional Classification
Calcium hydrogenphosphate
E00294
24441
Diluent
Carmellose sodium
E00625
Not Available
Disintegrant
Eisenoxyd
E00585
56841934
Colorant
Magnesium stearate
E00208
11177
lubricant
Meglumine
E00181
8567
Buffering agent
Silicon dioxide
E00670
Not Available
Anticaking agent; Opacifying agent; Viscosity-controlling agent
--------------------